Skip to headlines

BUSINESS

Moderna, Merck Fall After Melanoma Data Leak

Bloomberg MarketsThursday, October 22, 2026 at 8:28 PM

RedScroll Brief

Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived. Michelle Fay Cortez has more on "Bloomberg The Close.

RedScroll Signal

Impact
High
Category
Business
Market relevance
High
Why it matters
Corporate and market moves reprice risk and reveal where power and cash are concentrating. Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived. Michelle Fay Cortez has more on "Bloomberg The Close. Investors will watch earnings, rates, and competitive positioning connected to Moderna and Merck Fall After.

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived. Michelle Fay Cortez has more on "Bloomberg The Close.

Why it matters

Corporate and market moves reprice risk and reveal where power and cash are concentrating.

Background

Bloomberg Markets reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

  1. Bloomberg Markets published: Moderna, Merck Fall After Melanoma Data Leak

  2. Story is in today’s RedScroll edition. Follow the original source for updates.

Economic impact

Investors will watch earnings, rates, and competitive positioning connected to Moderna and Merck Fall After.

More on

Related stories

Source

Bloomberg Markets

Original reporting by Bloomberg Markets. RedScroll provides an extractive briefing only.